Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM

Recently, we developed novel chiral dendrimer-triamine-coordinated Gd-MRI contrast agents (Gd-MRI CAs), which showed longitudinal relaxivity (r(1)) values about four times higher than that of clinically used Gd-DTPA (Magnevist(®), Bayer). In our continuing study of pharmacokinetic differences derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Yuka, Ishikawa, Syungo, Kimura, Yu, Son, Aoi, Imai, Hirohiko, Matsuda, Tetsuya, Yamada, Hisatsugu, Toshimitsu, Akio, Kondo, Teruyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721819/
https://www.ncbi.nlm.nih.gov/pubmed/26694418
http://dx.doi.org/10.3390/s151229900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721819/
https://www.ncbi.nlm.nih.gov/pubmed/26694418
http://dx.doi.org/10.3390/s151229900

Ejemplares similares